Studies of the Toxicological Potential of Capsinoids, XIII: Inhibitory Effects of Capsaicin and Capsinoids on Cytochrome P450 3A4 in Human Liver Microsomes

被引:22
|
作者
Takanohashi, Toshiyuki [1 ]
Isaka, Mitsuyoshi
Ubukata, Kazuyuki
Mihara, Ryuichi
Bernard, Bruce K. [2 ]
机构
[1] Ajinomoto Co Inc, Pharmaceut Co, Pharmaceut Res Labs, Nonclin Dev Res Dept,Kawasaki Ku, Kanagawa, Japan
[2] SRA Int Inc, Cambridge, MD USA
关键词
capsaicin; capsinoids; human liver microsomes; cytochrome P450 3A4; CH-19 SWEET EXTRACT; COMMERCIAL-GRADE DIHYDROCAPSIATE; SINGLE-DOSE TOXICITY; IN-VITRO; DRUG-INTERACTIONS; 13-WEEK TOXICITY; CAPSICUM-ANNUUM; RATS; METABOLISM; PEPPER;
D O I
10.1177/1091581809360282
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study evaluated potential effects of a number of capsinoids (ie, capsiate, dihydrocapsiate, nordihydrocapsiate) and a single capsaicinoid (ie, capsaicin) on liver microsomal cytochrome P450 3A4-mediated midazolam I'-hydroxylase activity. Where possible, an inhibition curve was prepared; the concentration at which enzyme activity dropped to 50% was calculated. Capsaicin clearly inhibited cytochrome P450 3A4 activity, losing 50% of the activity at 21.5 mu mol/L. No enzyme inhibition was observed in the presence of capsiate, dihydrocapsiate, or nordihydrocapsiate (<100 mu mol/L). Preincubation increased the capsaicin inhibitory activity against cytochrome P450 3A4 in a time-dependent manner. Enzyme activity was slightly reduced by capsiate, dihydrocapsiate, and nordihydrocapsiate to the same level as that attained with tolbutamide, the negative control compound. Capsaicin was shown to inhibit cytochrome P450 3A4, probably through a mechanism-based inhibition. In contrast, capsiate, dihydrocapsiate, and nordihydrocapsiate did not inhibit cytochrome P450 3A4 activity and were unlikely to be mechanism-based inhibitors of CYP3A4.
引用
收藏
页码:22S / 26S
页数:5
相关论文
共 50 条
  • [21] Constituents of St. John's Wort inhibit cytochrome P450 3A4 and P450 reductase activity in human liver microsomes.
    Carson, SW
    Hill-Zabala, CE
    Blalock, SB
    Hoyler, SL
    Clarke, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P8 - P8
  • [22] Cytochrome P450 3A4 Inhibitory Activity Studies within the Lycorine series of Alkaloids
    McNulty, James
    Nair, Jerald J.
    Singh, Mohini
    Crankshaw, Denis J.
    Holloway, Alison C.
    Bastida, Jaume
    NATURAL PRODUCT COMMUNICATIONS, 2010, 5 (08) : 1195 - 1200
  • [23] Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes
    Yang, LQ
    Yu, WF
    Cao, YF
    Gong, B
    Chang, Q
    Yang, GS
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) : 1959 - 1962
  • [24] Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity
    Kimura, Yuka
    Ito, Hideyuki
    Ohnishi, Ryoko
    Hatano, Tsutomu
    FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (01) : 429 - 435
  • [25] Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes
    Li-Qun Yang Wei-Feng Yu Yun-Fei Cao Department of Anesthesiology
    World Journal of Gastroenterology, 2003, 9 (09) : 1959 - 1962
  • [26] Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4
    Kondza, Martin
    Rimac, Hrvoje
    Males, Zeljan
    Turcic, Petra
    Cavar, Ivan
    Bojic, Mirza
    CROATICA CHEMICA ACTA, 2020, 93 (01) : 33 - 39
  • [27] Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants
    Yamaguchi, Yuki
    Akiyoshi, Takeshi
    Kawamura, Go
    Imaoka, Ayuko
    Miyazaki, Mitsue
    Guengerich, F. Peter
    Nakamura, Katsunori
    Yamamoto, Koujirou
    Ohtani, Hisakazu
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 38
  • [28] Cytochrome P450 3A4 Inhibitory Constituents of the Wood of Taxus yunnanensis
    Tezuka, Yasuhiro
    Morikawa, Kouhei
    Li, Feng
    Auw, Lidyawati
    Awale, Suresh
    Nobukawa, Takahiro
    Kadota, Shigetoshi
    JOURNAL OF NATURAL PRODUCTS, 2011, 74 (01): : 102 - 105
  • [29] Inhibitory Effects of Cedrol, β-Cedrene, and Thujopsene on Cytochrome P450 Enzyme Activities in Human Liver Microsomes
    Jeong, Hyeon-Uk
    Kwon, Soon-Sang
    Kong, Tae Yeon
    Kim, Ju Hyun
    Lee, Hye Suk
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2014, 77 (22-24): : 1522 - 1532
  • [30] METABOLIC ACTIVATION OF THE INDOLOQUINAZOLINE ALKALOIDS EVODIAMINE AND RUTAECARPINE BY HUMAN LIVER MICROSOMES: DEHYDROGENATION AND INACTIVATION OF CYTOCHROME P450 3A4
    Wen, Bo
    DRUG METABOLISM REVIEWS, 2012, 44 : 112 - 112